Repatha Linked to 20% Lower Heart Attack Risk Than Ezetimibe in Real-World Study
A real-world study reports Repatha lowered heart attack risk by 20% compared with ezetimibe. The supplied body is truncated and provides no further details.
Story updates
02:04:45 PM UTC
SquawkNews
Large real-world analysis in 544,103 adults with ASCVD and prior statin use found Repatha lowered fa